Watchlist Price Alert

Kiniksa Pharmaceuticals L... (KNSA)

NASDAQ: KNSA · Real-Time Price · USD

26.81

0.78 (3.00%)

At close: May 12, 2025, 3:59 PM

26.84

0.11%

After-hours: May 12, 2025, 04:05 PM EDT

Kiniksa Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	423.24M	270.26M	220.18M	38.54M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	60.91M	56.52M	46.97M	9.1M	3.81M	3.28M	286K	28K	22K
Gross Profit	362.33M	213.74M	173.21M	29.44M	-3.81M	-3.28M	-286K	-28K	-22K
Operating Income	-45.62M	-25.2M	7.37M	-156.64M	-157.36M	-169.96M	-108.16M	-65.4M	-24M
Interest Income	n/a	8.54M	1.25M	97K	1.13M	6.05M	4.72M	529K	65K
Pretax Income	-36.15M	-16.65M	11.03M	-156.54M	-156.23M	-163.91M	-103.44M	-64.87M	-23.94M
Net Income	-43.19M	14.08M	183.36M	-157.92M	-161.38M	-161.87M	-103.23M	-64.87M	-23.97M
Selling & General & Admin	168.01M	129.43M	97.95M	85.95M	45.32M	34.96M	21.56M	9.04M	6.56M
Research & Development	111.62M	76.1M	65.49M	99.3M	112.04M	135M	86.6M	56.36M	17.44M
Other Expenses	128.31M	33.41M	1.25M	835K	n/a	n/a	n/a	n/a	n/a
Operating Expenses	407.94M	238.93M	163.44M	186.08M	157.36M	169.96M	108.16M	65.4M	24M
Interest Expense	n/a	n/a	1.25M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	468.86M	295.45M	210.41M	195.18M	157.36M	169.96M	108.16M	65.4M	24M
Income Tax Expense	7.04M	-30.74M	-172.34M	1.39M	5.15M	-2.05M	-214K	2K	36K
Shares Outstanding (Basic)	71.42M	70.06M	69.38M	68.58M	61.84M	54.05M	29.55M	32.47M	32.47M
Shares Outstanding (Diluted)	71.42M	71.92M	70.42M	68.58M	61.84M	54.05M	29.55M	32.47M	32.47M
EPS (Basic)	-0.6	0.20	2.64	-2.3	-2.61	-2.99	-3.49	-2	-0.74
EPS (Diluted)	-0.6	0.20	2.60	-2.3	-2.61	-2.99	-3.49	-2	-0.74
EBITDA	-45.62M	-22.86M	9.77M	-154.28M	-152.42M	-167.9M	-107.87M	-65.37M	-23.98M
EBIT	-45.62M	-25.2M	11.03M	-156.64M	-156.23M	-163.91M	-108.16M	-65.4M	-24M
Depreciation & Amortization	n/a	2.34M	4.22M	4.09M	3.81M	3.28M	286K	28K	22K